OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumour-infiltrating lymphocytes in non-invasive breast cancer: A systematic review and meta-analysis
Rafael Caparica, Marco Bruzzone, Elisa Agostinetto, et al.
The Breast (2021) Vol. 59, pp. 183-192
Open Access | Times Cited: 17
Rafael Caparica, Marco Bruzzone, Elisa Agostinetto, et al.
The Breast (2021) Vol. 59, pp. 183-192
Open Access | Times Cited: 17
Showing 17 citing articles:
Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer: Prognostic and Predictive Significance across Molecular Subtypes
Aleksandra Ciarka, Michał Piątek, Rafał Pęksa, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 763-763
Open Access | Times Cited: 19
Aleksandra Ciarka, Michał Piątek, Rafał Pęksa, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 763-763
Open Access | Times Cited: 19
A Comprehensive Review on Electrochemical Nano Biosensors for Precise Detection of Blood-Based Oncomarkers in Breast Cancer
Mahdi Sadeghi, Somayeh Sadeghi, Seyed Morteza Naghib, et al.
Biosensors (2023) Vol. 13, Iss. 4, pp. 481-481
Open Access | Times Cited: 17
Mahdi Sadeghi, Somayeh Sadeghi, Seyed Morteza Naghib, et al.
Biosensors (2023) Vol. 13, Iss. 4, pp. 481-481
Open Access | Times Cited: 17
Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligence
Shorouk Makhlouf, Noorul Wahab, Michael S. Toss, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 11, pp. 1747-1758
Open Access | Times Cited: 17
Shorouk Makhlouf, Noorul Wahab, Michael S. Toss, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 11, pp. 1747-1758
Open Access | Times Cited: 17
Epigenetic oncogenesis, biomarkers and emerging chemotherapeutics for breast cancer
Yusuf Oloruntoyin Ayipo, Abdulfatai Temitope Ajiboye, Wahab Adesina Osunniran, et al.
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2022) Vol. 1865, Iss. 7, pp. 194873-194873
Closed Access | Times Cited: 20
Yusuf Oloruntoyin Ayipo, Abdulfatai Temitope Ajiboye, Wahab Adesina Osunniran, et al.
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2022) Vol. 1865, Iss. 7, pp. 194873-194873
Closed Access | Times Cited: 20
Multimodal histopathologic models stratify hormone receptor-positive early breast cancer
Kevin M. Boehm, Omar S.M. El Nahhas, Antonio Marra, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Kevin M. Boehm, Omar S.M. El Nahhas, Antonio Marra, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Multimodal histopathologic models stratify hormone receptor-positive early breast cancer
Kevin M. Boehm, Omar S.M. El Nahhas, Antonio Marra, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Kevin M. Boehm, Omar S.M. El Nahhas, Antonio Marra, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial
Aglaia Schiza, Viktoria Thurfjell, Axel Stenmark Tullberg, et al.
European Journal of Cancer (2022) Vol. 168, pp. 128-137
Open Access | Times Cited: 14
Aglaia Schiza, Viktoria Thurfjell, Axel Stenmark Tullberg, et al.
European Journal of Cancer (2022) Vol. 168, pp. 128-137
Open Access | Times Cited: 14
Identifying recurrences and metastasis after ductal carcinoma in situ (DCIS ) of the breast
Ruwangi I Udayasiri, Tongtong Luo, Kylie L. Gorringe, et al.
Histopathology (2022) Vol. 82, Iss. 1, pp. 106-118
Open Access | Times Cited: 8
Ruwangi I Udayasiri, Tongtong Luo, Kylie L. Gorringe, et al.
Histopathology (2022) Vol. 82, Iss. 1, pp. 106-118
Open Access | Times Cited: 8
Clinicopathologic Features and Immune Cell Subtypes Analysis of Tumor-infiltrating Lymphocytes Rich Invasive Breast Carcinoma of No Special Type
Yan Zhao, Ting Huang, Xin Jin, et al.
Applied immunohistochemistry & molecular morphology (2023)
Open Access | Times Cited: 4
Yan Zhao, Ting Huang, Xin Jin, et al.
Applied immunohistochemistry & molecular morphology (2023)
Open Access | Times Cited: 4
Tumor-Infiltrating Lymphocytes in HER2-Low Breast Cancer
Ítalo Fernandes, Anderson Paulo Scorsato, Rafael Aliosha Kaliks, et al.
Clinical Breast Cancer (2023) Vol. 23, Iss. 7, pp. e470-e479
Closed Access | Times Cited: 4
Ítalo Fernandes, Anderson Paulo Scorsato, Rafael Aliosha Kaliks, et al.
Clinical Breast Cancer (2023) Vol. 23, Iss. 7, pp. e470-e479
Closed Access | Times Cited: 4
Evaluation of tumor infiltrating lymphocytes as a prognostic biomarker in patients with ductal carcinoma in situ of the breast
Camila Vitola Pasetto, Fernando Nalesso Aguiar, Marcella Bassan Peixoto, et al.
Breast Cancer Research and Treatment (2024) Vol. 208, Iss. 1, pp. 9-18
Closed Access | Times Cited: 1
Camila Vitola Pasetto, Fernando Nalesso Aguiar, Marcella Bassan Peixoto, et al.
Breast Cancer Research and Treatment (2024) Vol. 208, Iss. 1, pp. 9-18
Closed Access | Times Cited: 1
TIME Is Critical for Oncolytic Viral Therapies Against Solid Cancers
Vijay Kumar, John H. Stewart
Interdisciplinary cancer research (2024)
Closed Access | Times Cited: 1
Vijay Kumar, John H. Stewart
Interdisciplinary cancer research (2024)
Closed Access | Times Cited: 1
Integrating traditional biomarkers and emerging predictors to assess neoadjuvant chemotherapy efficacy in breast cancer: a multifactorial analysis of Ki-67, CDK4, EGFR, TILs and ctDNA
Tianzhao Du, Ye Yuan, Shulan Sun, et al.
BMC Women s Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Tianzhao Du, Ye Yuan, Shulan Sun, et al.
BMC Women s Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
The prognostic value of tumor-infiltrating lymphocytes in non-small cell lung cancer patients who received neoadjuvant chemotherapy followed by surgery
Zexin Hou, Lili Zhao, Lingjun Zou, et al.
Advances in Clinical and Experimental Medicine (2023) Vol. 32, Iss. 8, pp. 847-853
Open Access | Times Cited: 2
Zexin Hou, Lili Zhao, Lingjun Zou, et al.
Advances in Clinical and Experimental Medicine (2023) Vol. 32, Iss. 8, pp. 847-853
Open Access | Times Cited: 2
Thematic trends and knowledge-map of tumor-infiltrating lymphocytes in breast cancer: a scientometric analysis
Jinan Shi, Lei Pan, Feixia Ma, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Jinan Shi, Lei Pan, Feixia Ma, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
DCIS AI-TIL: Ductal Carcinoma In Situ Tumour Infiltrating Lymphocyte Scoring Using Artificial Intelligence
Yeman Brhane Hagos, Faranak Sobhani, Simón P. Castillo, et al.
Lecture notes in computer science (2022), pp. 164-175
Closed Access | Times Cited: 1
Yeman Brhane Hagos, Faranak Sobhani, Simón P. Castillo, et al.
Lecture notes in computer science (2022), pp. 164-175
Closed Access | Times Cited: 1
Tumor microenvironment biomarkers in breast cancer
Pavel Sokolov, А. В. Караулов, Alyona Sukhanova, et al.
Russian Journal of Biotherapy (2023) Vol. 22, Iss. 1, pp. 19-27
Open Access
Pavel Sokolov, А. В. Караулов, Alyona Sukhanova, et al.
Russian Journal of Biotherapy (2023) Vol. 22, Iss. 1, pp. 19-27
Open Access
